Filters
Repeat chemosensitivity of epithelial ovarian carcinoma in a BRCA1 mutation carrier to paclitaxel/platinum combination chemotherapy
The patient had complete response to the combination of paclitaxel/platinum in the first line. Subseguent four recurrences also showed a complete response to this combination. The chronic toxicity, including hypersensitivity and nep...
FD - Onkologie a hematologie
- 2009 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Serial urinary neopterin measurements reflect the disease course in patients with epithelial ovarian carcinoma treated with paclitaxel/platinum chemotherapy
Monitoring of serial urinary neopterin in patients with epithelial ovarian carcinoma treated with paclitaxel/platinum chemotherapy......
FD - Onkologie a hematologie
- 2007 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum
Combination of platinum derivates with paclitaxel is currently the standard front line regimen for patients with epithelial ovarian carcinoma and represents also an active regimen in patients with metastatic breast or unknown primar...
FD - Onkologie a hematologie
- 2007 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or - Refractory Ovarian Cancer
in combination with once-per-week paclitaxel compared with paclitaxel alone in patients with platinum-resistant or -refractory ovarian cancer. A key secondary objective......
FK - Gynekologie a porodnictví
- 2016 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Bevacizumab in the treatment of uterine cervix carcinoma
. Bevacizumab in combination with paclitaxel and cisplatin or alternatively in patients who cannot be treated with platinum, paclitaxel and topotecan, may be indicated......
Oncology
- 2020 •
- Jost •
- Link
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up
We present a prospective study of neoadjuvant CRT with or without paclitaxel in chemotherapy schedule. One hundred seven patients (93 males, 14 females), median age 59 years (range 44-76), with operable esophageal cancer were enrolled....
FD - Onkologie a hematologie
- 2010 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Bevacizumab in the treatment of uterine cervix carcinoma
. Bevacizumab in combination with paclitaxel and cisplatin or alternatively in patients who cannot be treated with platinum, paclitaxel and topotecan, may be indicated......
Oncology
- 2020 •
- O •
- Link
Rok uplatnění
O - Ostatní výsledky
Výsledek na webu
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
with platinum-sensitive, recurrent, high-grade serous ovarian cancer who had received up to three previous courses of platinum-based chemotherapy and who were progression free daily, administered orally on days 1-10 of each 21-day ...
FD - Onkologie a hematologie
- 2015 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
Major progress has been achieved during the past few decades in the therapy od epithelial ovarian carcinoma (EOC). Although the disease in most patients with advanced disease is still incurable, the survival has been substantially prolonged....
FD - Onkologie a hematologie
- 2012 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Treatment of ovarian cancer
Malignant ovarian tumors are among the tumors with the worst prognosis. About 75% of patients are diagnosed in III. and IV. stage of the disease. The primary treatment modality is radical surgery, optimally to zero residual. The basis of chemotherapy...
Oncology
- 2023 •
- O •
- Link
Rok uplatnění
O - Ostatní výsledky
Výsledek na webu
- 1 - 10 out of 2 324